title: Difficult asthma and Churg-Strauss-like syndrome: a cautionary tale.
authors.affiliation: Department of Respiratory , Royal Prince Alfred Hospital, Sydney, New South Wales, Australia.
authors.forename: Edmund M T
authors.initials: EM
authors.lastname: Lau
authors.forename: Wendy
authors.initials: W
authors.lastname: Cooper
authors.forename: Peter T
authors.initials: PT
authors.lastname: Bye
authors.forename: Kwok
authors.initials: K
authors.lastname: Yan
mesh_terms: D000328:Adult; D018926:Anti-Allergic Agents / Q000627:therapeutic use*; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use*; D000888:Antibodies, Anti-Idiotypic / Q000627:therapeutic use*; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized; D001249:Asthma / Q000150:complications / Q000188:drug therapy* / Q000473:pathology; D001706:Biopsy; D015267:Churg-Strauss Syndrome / Q000150:complications / Q000188:drug therapy* / Q000473:pathology; D004804:Eosinophils / Q000187:drug effects; D005260:Female; D006801:Humans; D008775:Methylprednisolone / Q000627:therapeutic use*; D009173:Mycophenolic Acid / Q000031:analogs & derivatives* / Q000627:therapeutic use; D000069444:Omalizumab; D011239:Prednisolone / Q000627:therapeutic use*; D016896:Treatment Outcome
chemical_list: D018926:Anti-Allergic Agents; D000893:Anti-Inflammatory Agents; D000888:Antibodies, Anti-Idiotypic; D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000069444:Omalizumab; D011239:Prednisolone; D009173:Mycophenolic Acid; D008775:Methylprednisolone